Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted oral protein degradation therapies. Dunad’s platform enables selective degradation via direct target modification using tunable mono-valent small molecules, allowing for the development of more drug-like, orally bioavailable and CNS-accessible protein degraders.
View Top Employees from Dunad TherapeuticsWebsite | https://www.dunadtx.com |
Employees | 35 (27 on RocketReach) |
Founded | 2020 |
Industry | Biotechnology Research |
Looking for a particular Dunad Therapeutics employee's phone or email?
Holly Whittemore is the Chief Operating Officer and Treasurer of Dunad Therapeutics.
27 people are employed at Dunad Therapeutics.